脊柱融合术中骨形态发生蛋白的当前使用情况及并发症:9809例患者回顾性分析
该回顾性电子健康记录研究纳入2016年2月至2022年1月接受脊柱融合术的9809例患者,比较rhBMP-2与非rhBMP-2使用的适应证和并发症率。rhBMP-2在AL/TF和LLIF中使用广泛,PCF和PL/TF中常用,TLIF中偶用,ACF中少用;PL/TF使用rhBMP-2者伤口裂开率增加,但总体无明显的rhBMP-2相关并发症趋势。
要点
- rhBMP-2使用率:ACF 0.3%、PCF 64.5%、AL/TF 96.1%、PL/TF 69.2%、LLIF 97.4%、TLIF 24.1%。
- PL/TF使用rhBMP-2者伤口裂开率增加,且骨质疏松、平均年龄、既往吸烟史和ASA分级更高。
- 长节段融合使用rhBMP-2者比短节段融合未使用rhBMP-2者更可能有骨质疏松。
核心结论
- rhBMP-2在AL/TF和LLIF中使用广泛,PCF和PL/TF中常用,TLIF中偶用,ACF中少用。
- 颈椎使用模式主要选择假关节形成风险因素患者,但该模式仅见于后路腰椎和胸椎融合。
- 未发现rhBMP-2使用相关的明显并发症趋势。
研究设计与样本
- 回顾性电子健康记录系统综述,纳入2016年2月至2022年1月接受脊柱融合术的患者,共9809例。
- 手术类型按主要术式入路分类,并对短节段和长节段融合中rhBMP-2使用差异进行亚组分析。
- 评估术后一年内以ICD-10编码记录的并发症。
主要发现
- rhBMP-2使用率:ACF 0.3%、PCF 64.5%、AL/TF 96.1%、PL/TF 69.2%、LLIF 97.4%、TLIF 24.1%。
- PCF使用rhBMP-2者骨质疏松率更高。
- PL/TF使用rhBMP-2者骨质疏松率、平均年龄、既往吸烟状态和ASA分级更高,且伤口裂开率增加。
- 长节段融合使用rhBMP-2者比短节段融合未使用rhBMP-2者更可能有骨质疏松。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective review of electronic health records system. OBJECTIVE: To compare the indications and complication rates between rhBMP-2 and non-rhBMP-2 use in spine fusion at a high-volume tertiary orthopedic institution. SUMMARY OF BACKGROUND DATA: Bone morphogenetic proteins are growth factors that play a critical role in bone development and proliferation. rhBMP-2 is a biological approved for select spinal fusion procedures to improve fusion rates. It is used in off-label indications. There are limited studies describing the use of rhBMP-2 in current practice. MATERIALS AND METHODS: Patients who underwent spinal fusion from February 2016 to January 2022 were included. Surgery types were categorized by the approach listed as the primary procedure. A subgroup analysis was performed to assess differences in rhBMP-2 use for short and long fusions. Complications present within one year as ICD-10 codes were assessed. RESULTS: A total of 9809 patients were assessed. rhBMP-2 was used in 0.3% of ACF and 64.5% of PCF surgeries. Patients who underwent PCF with rhBMP-2 had higher rates of osteoporosis. rhBMP-2 was used in 96.1% of AL/TF, 69.2% of PL/TF, 97.4% of LLIF, and 24.1% of TLIF. Patients who underwent PL/TF with rhBMP-2 had higher rates of osteoporosis, mean age, former smoking status, and ASA class. There were increased rates of wound dehiscence in PL/TF with rhBMP-2. Patients who underwent long fusions with rhBMP-2 were more likely to have osteoporosis than those who underwent short fusions without rhBMP-2. CONCLUSIONS: We found that rhBMP-2 was used extensively in AL/TF and LLIF, frequently in PCF and PL/TF, occasionally in TLIF, and sparingly in ACF. While patterns of use differed in the cervical spine, mostly selecting for patients with risk factors for pseudarthrosis, this pattern of usage was only found in posterior lumbar and thoracic fusion. There was no obvious trend in complications associated with rhBMP-2 use.
引用
- Korsun MK, Asada T, Hirase T, et al. Current Use and Complications Associated With Bone Morphogenetic Protein in Spine Fusion Surgery: A Review of 9809 Patients. Spine (Phila Pa 1976). 2025. PMID: 40833118. doi:10.1097/BRS.0000000000005372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。